Log in
Enquire now
‌

US Patent 9029081 Characterization of N-glycans using exoglycosidases

Patent 9029081 was granted and assigned to Momenta Pharmaceuticals on May, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Momenta Pharmaceuticals
Momenta Pharmaceuticals
Current Assignee
Momenta Pharmaceuticals
Momenta Pharmaceuticals
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9029081
Patent Inventor Names
Lakshmanan Thiruneelakantapillai0
Carlos J. Bosques0
Dorota A. Bulik0
Ian Christopher Parsons0
Brian Edward Collins0
Date of Patent
May 12, 2015
Patent Application Number
13720192
Date Filed
December 19, 2012
Patent Primary Examiner
‌
Bin Shen
Patent abstract

The present disclosure provides methods for analyzing structure and/or composition of N-glycans. Such methods often involve digestion of N-glycans with multiple exoglycosidases. In some embodiments, N-glycans are digested with multiple exoglycosidases simultaneously. In some embodiments, N-glycans are digested with multiple exoglycosidases sequentially. In some embodiments, methods in accordance with the present disclosure involve comparison of cleavage products of N-glycans that have been digested with multiple exoglycosidases simultaneously to N-glycans that have been digested with multiple exoglycosidases sequentially.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9029081 Characterization of N-glycans using exoglycosidases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.